Susquehanna International Group
TCRT icon

Susquehanna International Group’s Alaunos Therapeutics TCRT Stock Holding History

Susquehanna International Group’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,058
Closed -$80.9K – 12960
2023
Q2 		$80.9K Buy
1,058
+307
+41% +$24.8K ﹤0.01% 11101
2023
Q1 		$71K Sell
751
-399
-35% -$38K ﹤0.01% 11524
2022
Q4 		$112K Sell
1,150
-878
-43% -$127K ﹤0.01% 10849
2022
Q3 		$523K Buy
2,028
+1,009
+99% +$293K ﹤0.01% 8363
2022
Q2 		$189K Buy
1,019
+165
+19% +$15.8K ﹤0.01% 10717
2022
Q1 		$83K Sell
854
-537
-39% -$68.9K ﹤0.01% 12029
2021
Q4 		$227K Sell
1,391
-1,367
-50% -$300K ﹤0.01% 11181
2021
Q3 		$753K Sell
2,758
-361
-12% -$110K ﹤0.01% 8304
2021
Q2 		$1.24M Buy
3,119
+726
+30% +$339K ﹤0.01% 7161
2021
Q1 		$1.29M Sell
2,393
-1,337
-36% -$832K ﹤0.01% 7046
2020
Q4 		$1.41M Sell
3,730
-80
-2% -$31.8K ﹤0.01% 5873
2020
Q3 		$1.44M Buy
3,810
+308
+9% +$136K ﹤0.01% 5260
2020
Q2 		$1.72M Sell
3,502
-2,339
-40% -$1.04M ﹤0.01% 4764
2020
Q1 		$2.15M Sell
5,841
-348
-6% -$180K ﹤0.01% 3846
2019
Q4 		$4.38M Buy
6,189
+2,470
+66% +$1.7M ﹤0.01% 3163
2019
Q3 		$2.39M Sell
3,719
-1,109
-23% -$880K ﹤0.01% 3865
2019
Q2 		$4.22M Buy
4,828
+2,505
+108% +$1.72M ﹤0.01% 2948
2019
Q1 		$1.34M Buy
2,323
+202
+10% +$84.5K ﹤0.01% 4437
2018
Q4 		$595K Buy
2,121
+779
+58% +$308K ﹤0.01% 5700
2018
Q3 		$644K Sell
1,342
-751
-36% -$322K ﹤0.01% 6078
2018
Q2 		$948K Sell
2,093
-150
-7% -$95.1K ﹤0.01% 5471
2018
Q1 		$1.32M Sell
2,243
-2,466
-52% -$1.54M ﹤0.01% 4692
2017
Q4 		$2.92M Sell
4,709
-438
-9% -$315K ﹤0.01% 3288
2017
Q3 		$4.74M Sell
5,147
-624
-11% -$554K ﹤0.01% 2561
2017
Q2 		$5.38M Sell
5,771
-976
-14% -$957K ﹤0.01% 2315
2017
Q1 		$6.42M Sell
6,747
-1,306
-16% -$1.22M ﹤0.01% 2080
2016
Q4 		$6.46M Sell
8,053
-1,708
-17% -$1.54M ﹤0.01% 2054
2016
Q3 		$8.24M Buy
9,761
+1,256
+15% +$1.01M ﹤0.01% 1680
2016
Q2 		$7M Sell
8,505
-300
-3% -$327K ﹤0.01% 1799
2016
Q1 		$9.8M Sell
8,805
-5,212
-37% -$5.33M 0.01% 1577
2015
Q4 		$17.5M Buy
14,017
+2,024
+17% +$3.35M 0.01% 1246
2015
Q3 		$16.2M Buy
11,993
+4,238
+55% +$6.99M 0.01% 1402
2015
Q2 		$14M Buy
7,755
+3,658
+89% +$5.68M 0.01% 1649
2015
Q1 		$6.62M Buy
4,097
+522
+15% +$774K ﹤0.01% 2354
2014
Q4 		$2.72M Sell
3,575
-560
-14% -$297K ﹤0.01% 3899
2014
Q3 		$1.64M Buy
4,135
+207
+5% +$99.8K ﹤0.01% 4983
2014
Q2 		$2.37M Buy
3,928
+1,959
+99% +$1.09M ﹤0.01% 4327
2014
Q1 		$1.35M Sell
1,969
-1,942
-50% -$1.3M ﹤0.01% 4983
2013
Q4 		$2.55M Buy
3,911
+1,017
+35% +$606K ﹤0.01% 3884
2013
Q3 		$1.72M Sell
2,894
-108
-4% -$48.7K ﹤0.01% 4370
2013
Q2 		$950K Buy
+3,002
New +$834K ﹤0.01% 5077

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Susquehanna International Group's TCRT Position: Q1 2024 in Review

Susquehanna International Group sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 931 shares — an estimated $9.87K sold.

Susquehanna International Group first reported a position in TCRT in Q2 2013 and held it in 43 quarters. The position peaked at $49.1M in Q2 2017. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Susquehanna International Group reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 931 Alaunos Therapeutics shares in Q1 2024, an estimated $9.87K.
  • Susquehanna International Group first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 43 quarters.
  • Susquehanna International Group's Alaunos Therapeutics position peaked at $49.1M in Q2 2017.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.